Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gaudernack

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
International Journal of Cancer|January 8, 1998
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factorsJ Breivik, R A Lothe, G I Meling, et al.
Scandinavian Journal of Gastroenterology|January 1, 1997
K-ras mutations and prognosis in large-bowel carcinomasS N Andersen, T Løvig, J Breivik, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 26, 1999
Culture characterization of differentiated high endothelial venule cells from human tonsilsE S Baekkevold, F L Jahnsen, F E Johansen, et al.
Human Immunology|October 1, 1995
Influence on antibody recognition of amino acid substitutions in the cleft of HLA-DQ2 molecules. Suggestive evidence of peptide-dependent epitopesH D Viken, G Paulsen, S Drover, et al.
British Journal of Haematology|January 1, 1988
Characterization of a monoclonal antibody ITI-Pl 1 directed against human platelet membrane glycoprotein IIb using extracts of whole platelets and platelet surface and intracellular membranesL I Thorsen, G Gaudernack, N Hack, et al.
Lancet (London, England)|November 25, 1995
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutationM K Gjertsen, A Bakka, J Breivik, et al.
Human Immunology|April 1, 1995
Characterization of an HLA-DQ2-specific monoclonal antibody. Influence of amino acid substitutions in DQ beta 1*0202H D Viken, G Paulsen, L M Sollid, et al.
European Journal of Immunology|July 1, 1989
Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigensH Holte, H K Blomhoff, K Beiske, et al.
Tissue Antigens|March 1, 1995
RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A moleculesR D Pettersen, K Hestdal, N Lee, et al.
British Journal of Cancer|October 25, 2006
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II studyS L Bernhardt, M K Gjertsen, S Trachsel, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|January 8, 1998
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factorsJ Breivik, R A Lothe, G I Meling, et al.
Scandinavian Journal of Gastroenterology|January 1, 1997
K-ras mutations and prognosis in large-bowel carcinomasS N Andersen, T Løvig, J Breivik, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 26, 1999
Culture characterization of differentiated high endothelial venule cells from human tonsilsE S Baekkevold, F L Jahnsen, F E Johansen, et al.
Human Immunology|October 1, 1995
Influence on antibody recognition of amino acid substitutions in the cleft of HLA-DQ2 molecules. Suggestive evidence of peptide-dependent epitopesH D Viken, G Paulsen, S Drover, et al.
British Journal of Haematology|January 1, 1988
Characterization of a monoclonal antibody ITI-Pl 1 directed against human platelet membrane glycoprotein IIb using extracts of whole platelets and platelet surface and intracellular membranesL I Thorsen, G Gaudernack, N Hack, et al.
Lancet (London, England)|November 25, 1995
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutationM K Gjertsen, A Bakka, J Breivik, et al.
Human Immunology|April 1, 1995
Characterization of an HLA-DQ2-specific monoclonal antibody. Influence of amino acid substitutions in DQ beta 1*0202H D Viken, G Paulsen, L M Sollid, et al.
European Journal of Immunology|July 1, 1989
Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigensH Holte, H K Blomhoff, K Beiske, et al.
Tissue Antigens|March 1, 1995
RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A moleculesR D Pettersen, K Hestdal, N Lee, et al.
British Journal of Cancer|October 25, 2006
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II studyS L Bernhardt, M K Gjertsen, S Trachsel, et al.
Pageof 16